NCT06415903
A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer No drug interventions treatment 1 not_yet_recruiting NCT06131216
Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors No drug interventions treatment 1 not_yet_recruiting NCT05162469
A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT05983146
Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04980690
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05082545
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors treatment 1 completed NCT05991583
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05110807
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT05728541
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 not_yet_recruiting NCT05877924
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors. No drug interventions treatment 1 recruiting NCT05779163
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT06167486
SG2918 For Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT05214482
A Study of AK112 in Advanced Malignant Tumors treatment 1 / 2 recruiting NCT05223231
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05868876
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors treatment 1 recruiting NCT05396391
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT04708210
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 active_not_recruiting NCT05193721
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 active_not_recruiting NCT05653284
A Study of AK130 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 completed NCT05229497
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors No drug interventions treatment 1 / 2 unknown_status NCT04128085
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT05235542
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors No drug interventions treatment 1 / 2 unknown_status NCT06223841
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05198817
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients No drug interventions treatment 1 unknown_status NCT06226363
Phase I Study of LNF1901 in Advanced Malignant Tumors No drug interventions treatment 1 not_yet_recruiting NCT05354076
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo No drug interventions treatment 2 unknown_status NCT04412564
A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor No drug interventions treatment 2 unknown_status NCT05318833
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT05198505
Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT05015309
A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor No drug interventions treatment 1 unknown_status NCT04954456
A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies No drug interventions treatment 1 unknown_status NCT05416359
Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 unknown_status NCT05767060
BAT7104 Injection in Patients With Advanced Malignant Tumors. No drug interventions treatment 1 recruiting NCT04326829
QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT05851092
Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT06059508
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT05042908
Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT05144061
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT05089461
A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor No drug interventions treatment 2 suspended NCT04739111
An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor No drug interventions treatment 1 unknown_status NCT04296994
A Study of QL1706 in Subjects With Advanced Malignant Tumor No drug interventions treatment 1 active_not_recruiting NCT04975204
A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 unknown_status NCT06022250
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor No drug interventions treatment 1 recruiting NCT00813384
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01253707
A Study of AMG 337 in Subjects With Advanced Solid Tumors treatment 1 completed NCT02743637
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors treatment 1 completed NCT02437916
Safety Study of AMG 228 to Treat Solid Tumors No drug interventions treatment 1 terminated NCT04216082
A Study of Anlotinib in Subjects With Advanced Malignancy treatment 2 completed NCT02978482
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies treatment 1 completed NCT02016729
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia treatment 1 completed NCT01945164
XL999 Administered Intravenously to a Subject With Advanced Malignancies No drug interventions Not Available Not Available no_longer_available NCT00858377
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas No drug interventions treatment 3 completed NCT00428545
Bevacizumab and Bortezomib in Patients With Advanced Malignancy No drug interventions treatment 1 completed NCT01558817
Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation With Informed Assent No drug interventions Not Available Not Available completed NCT00974896
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03875157
Study of IBI318 in Participants With Advanced Malignancies No drug interventions treatment 1 completed NCT00978926
A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies No drug interventions Not Available Not Available completed NCT01723020
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma No drug interventions treatment 1 completed NCT01444404
A Study of AMG 820 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02110355
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma No drug interventions treatment 1 completed NCT03717103
A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies No drug interventions treatment 1 completed NCT00741403
A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT01079702
Everolimus and Capecitabine in Patients With Advanced Malignancy No drug interventions treatment 1 / 2 unknown_status NCT00955084
Maintenance Study on the Long Term Safety of XL999 No drug interventions treatment 1 completed NCT05987605
Clinical Study of 1A46 Drug Substance No drug interventions other 1 not_yet_recruiting NCT05024305
Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies. No drug interventions treatment 1 unknown_status NCT02862561
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer No drug interventions treatment 1 / 2 unknown_status NCT06202261
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer treatment 1 / 2 recruiting NCT00779428
Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin treatment 2 completed NCT06401356
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib treatment 3 not_yet_recruiting NCT04085185
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors treatment 1 unknown_status NCT04537715
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels treatment 1 completed NCT02959437
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206) treatment 1 / 2 terminated NCT00676299
A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. No drug interventions treatment 1 completed NCT01930006
Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State treatment 1 completed NCT03763149
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas treatment 1 completed NCT04916119
Study of IBI323 in Patients With Advanced Malignancies No drug interventions treatment 1 unknown_status NCT05048134
A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies treatment 1 recruiting NCT00420524
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function treatment 1 completed NCT05245916
IBI397 or Combination Therapies in Patients With Advanced Malignancies treatment 1 withdrawn NCT04831996
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment. other 1 completed NCT00448396
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies treatment 1 completed NCT05391022
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies treatment 1 completed NCT04651348
A Clinical Study of MIL95 in Advanced Malignancies. No drug interventions treatment 1 recruiting NCT04025957
A Study of SHR-1501 in Patients With Advanced Tumors No drug interventions treatment 1 completed NCT04752826
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) treatment 1 / 2 recruiting NCT03241173
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies treatment 1 / 2 completed NCT04340427
A Study of TQB3455 Tablets in Subjects With Advanced Malignancies No drug interventions treatment 1 unknown_status NCT03407976
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies treatment 1 terminated NCT00468260
The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies treatment 1 terminated NCT04949191
The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. treatment 2 terminated NCT02697591
A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT01284192
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) treatment 1 completed NCT04831944
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment. other 1 completed NCT00421044
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function treatment 1 completed NCT03474640
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies treatment 1 unknown_status NCT02737501
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants treatment 3 completed NCT02013804
A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies treatment 1 completed NCT03995472
A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors treatment 1 completed NCT03907969
A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers. treatment 1 / 2 completed NCT00500903
A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02873390
PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT00651664
A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies No drug interventions treatment 1 completed NCT00679133
Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies No drug interventions treatment 1 completed NCT02520245
Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study No drug interventions treatment 1 withdrawn NCT06468098
A Study of IBI363 in Subjects With Advanced Malignancies No drug interventions treatment 1 recruiting NCT05351697
Phase I Clinical Study of BR105 Injection No drug interventions other 1 not_yet_recruiting NCT00948961
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1 No drug interventions treatment 1 / 2 completed NCT00611793
PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies No drug interventions treatment 1 completed NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers No drug interventions treatment 1 recruiting NCT04181788
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT06206915
Phase I Study of XZ120 in Malignant Tumors No drug interventions treatment 1 not_yet_recruiting NCT03277352
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies No drug interventions treatment 1 / 2 terminated NCT04671875
A Clinical Study of MIL93 in Solid Tumors. No drug interventions treatment 1 recruiting NCT04164199
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies No drug interventions treatment 3 enrolling_by_invitation NCT02923349
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 completed NCT03297424
A Study of PLX2853 in Advanced Malignancies. No drug interventions treatment 1 completed NCT04837196
Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen No drug interventions treatment 1 / 2 completed NCT06038058
A Phase I Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies No drug interventions treatment 1 not_yet_recruiting NCT00652158
A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies No drug interventions treatment 1 terminated NCT02784158
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available no_longer_available NCT03233139
Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing No drug interventions treatment 3 active_not_recruiting NCT00083525
Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies No drug interventions treatment 1 completed NCT00724425
A Phase 1 Dose Escalation Study of IPI-493 No drug interventions treatment 1 terminated NCT04353830
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-T-cell Immunoreceptor With Ig and ITIM Domains (TIGIT) Monoclonal Antibody Injection (IBI939) in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 completed NCT05577182
Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies No drug interventions treatment 1 active_not_recruiting NCT04328831
Safety and Efficacy of IBI322 in Chinese Subjects With Advanced Malignant Tumors No drug interventions treatment 1 completed NCT02678260
Phase I Study of PDR001 in Patients With Advanced Malignancies. No drug interventions treatment 1 completed NCT05359692
INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma No drug interventions treatment 2 withdrawn NCT00426140
Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. No drug interventions treatment 1 completed NCT03158272
A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread No drug interventions treatment 1 completed NCT02608268
Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies No drug interventions treatment 1 / 2 terminated NCT02383212
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT02265510
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies No drug interventions treatment 1 / 2 terminated NCT03126110
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies No drug interventions treatment 1 / 2 completed NCT01057264
HAI Abraxane With Gemcitabine and Bevacizumab No drug interventions treatment 1 completed NCT01832402
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea No drug interventions supportive_care 2 completed NCT01259284
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer No drug interventions treatment 2 / 3 terminated NCT02095054
Regorafenib and Cetuximab in Patients With Advanced Malignancy treatment 1 completed NCT06413953
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors No drug interventions treatment 1 recruiting NCT01952847
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis supportive_care 3 terminated NCT02801045
Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient No drug interventions supportive_care Not Available completed NCT01199198
Tolvaptan in Hyponatremic Cancer Patients treatment 4 completed NCT00934128
High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer No drug interventions treatment 2 completed NCT01532011
Erlotinib in Combination With Pralatrexate in Advanced Malignancies treatment 1 completed NCT02523378
Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion No drug interventions supportive_care Not Available completed NCT00851032
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol No drug interventions Not Available Not Available unknown_status NCT01744652
Dasatinib and Crizotinib in Advanced Cancer treatment 1 completed NCT02623959
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis treatment 4 terminated NCT02873975
A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency treatment 2 completed NCT02498899
Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion No drug interventions supportive_care Not Available completed NCT00941499
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab treatment 1 completed NCT06001749
Psilocybin in Cancer Pain Study treatment 2 not_yet_recruiting NCT02561234
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT01183663
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) treatment 1 completed NCT01636622
Study of Vemurafenib, Carboplatin, and Paclitaxel treatment 1 completed NCT01193530
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer No drug interventions treatment 2 / 3 terminated NCT01003626
Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients No drug interventions treatment Not Available withdrawn NCT01024166
Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study No drug interventions Not Available Not Available completed NCT05380882
Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers No drug interventions treatment 1 unknown_status NCT01201694
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) treatment 1 completed NCT02345629
Cordotomy for Refractory Cancer Pain No drug interventions treatment Not Available completed NCT02422329
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention No drug interventions supportive_care Not Available completed NCT02042989
MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies treatment 1 completed NCT00907192
Self Reported Deviations From Opioid Analgesic Prescription No drug interventions Not Available Not Available completed NCT00496444
Azacytidine and Valproic Acid in Patients With Advanced Cancers treatment 1 completed NCT01518140
BiPAP-Vapotherm RCT No drug interventions supportive_care 2 withdrawn NCT01454804
Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors treatment 1 completed NCT01021072
A First in Man Study of MABp1 in Patients With Advanced Cancers No drug interventions treatment 1 completed NCT01430572
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients treatment 1 completed NCT02459964
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain No drug interventions supportive_care 4 completed NCT02155621
Personalized Oncogenomics (POG) Program of British Columbia No drug interventions other Not Available recruiting NCT01563302
Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers No drug interventions treatment 1 / 2 completed NCT03726333
Hepatic Impairment Study for Lorlatinib in Cancer Patients No drug interventions treatment 1 terminated NCT00379353
The Effects of Thalidomide on Symptom Clusters No drug interventions supportive_care 2 completed NCT01670097
Dexamethasone Dyspnea Study No drug interventions treatment 2 completed NCT01087983
Lapatinib With Sirolimus or Metformin No drug interventions treatment 1 completed NCT01750983
Ipilimumab and Lenalidomide in Advanced Cancer No drug interventions treatment 1 completed NCT03375983
Plasmodium Immunotherapy for Advanced Cancers No drug interventions treatment 1 / 2 recruiting NCT01529593
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers No drug interventions treatment 1 active_not_recruiting NCT02597478
Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea No drug interventions treatment 2 / 3 completed NCT00909207
Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing No drug interventions Not Available Not Available completed NCT02514252
Sublingual Fentanyl for the Management of Breakthrough Pain No drug interventions treatment 2 terminated NCT02668770
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies No drug interventions treatment 1 active_not_recruiting NCT02571036
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT00732836
Hepatic Arterial Infusion (HAI) of Abraxane No drug interventions treatment 1 completed NCT00208013
The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients No drug interventions Not Available Not Available completed NCT01432119
Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib No drug interventions treatment 1 withdrawn NCT02437617
Genomic Profiling Assay in Phase I No drug interventions Not Available Not Available completed NCT01653717
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 1 completed NCT00903734
An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status No drug interventions treatment 1 completed NCT01608139
Study of Curcumin, Vorinostat, and Sorafenib No drug interventions treatment 1 withdrawn NCT01389830
End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer No drug interventions Not Available Not Available unknown_status NCT02558257
Perception of Palliative Care Encounter No drug interventions Not Available Not Available completed NCT01266057
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer No drug interventions treatment 1 completed NCT02160366
Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01515566
Breakthrough Dyspnea Fentanyl Study in Cancer Patients No drug interventions supportive_care 1 / 2 completed NCT02478320
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors No drug interventions treatment 2 terminated NCT00473720
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers No drug interventions treatment 1 completed NCT00499382
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging No drug interventions Not Available Not Available terminated NCT00877773
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients No drug interventions treatment 1 / 2 terminated NCT00836927
Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038) No drug interventions treatment 2 terminated NCT05333276
Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers No drug interventions treatment 1 active_not_recruiting NCT02521194
Occupational Therapy in Palliative Care No drug interventions supportive_care Not Available terminated NCT02508662
Registry Study for Personalized Cancer Therapy No drug interventions Not Available Not Available completed NCT01949662
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer No drug interventions supportive_care 2 active_not_recruiting NCT00895362
Erlotinib in Combination With Cetuximab No drug interventions treatment 1 completed NCT01548144
Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer No drug interventions treatment 1 terminated NCT01277744
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor No drug interventions treatment 2 completed NCT01011140
Physician Perceptions About Parenteral Hydration in Latin America and Spain No drug interventions Not Available Not Available unknown_status NCT01200004
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide No drug interventions treatment 1 terminated NCT02193672
A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy No drug interventions diagnostic 1 withdrawn NCT00939172
TTP607 in Refractory Solid Malignancies No drug interventions treatment 1 withdrawn NCT01983969
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma No drug interventions treatment 1 / 2 completed NCT01178112
Trientine and Carboplatin in Advanced Malignancies No drug interventions treatment 1 completed NCT02272595
Rational Therapeutics Based on Matched Tumor and Normal Tissue No drug interventions Not Available Not Available completed NCT01375114
The Effects of Ginseng on Cancer-Related Fatigue No drug interventions treatment 2 active_not_recruiting NCT01856114
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea No drug interventions treatment 2 completed NCT00903708
LY2275796 in Advanced Cancer No drug interventions treatment 1 completed NCT01213238
Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab No drug interventions treatment 1 completed NCT01999491
A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 active_not_recruiting NCT01976143
A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety No drug interventions treatment 1 completed NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer No drug interventions treatment 2 active_not_recruiting NCT05394103
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01152203
Bendamustine and Bevacizumab for Advanced Cancers No drug interventions treatment 1 completed NCT02407990
Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors No drug interventions treatment 1 completed NCT00949390
Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials No drug interventions Not Available Not Available completed NCT05917990
Dyadic Text-Messaging Micro-Intervention No drug interventions treatment Not Available not_yet_recruiting NCT01443390
An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer No drug interventions Not Available Not Available completed NCT04495790
AIMS Cancer Outcomes Study No drug interventions Not Available Not Available recruiting NCT05257590
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma No drug interventions treatment 2 recruiting NCT02658890
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread No drug interventions treatment 1 / 2 completed NCT00352664
The Effect of Donepezil on Sedation and Other Symptoms No drug interventions treatment 3 terminated NCT02944864
A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT00704821
PTC299 for Treatment of Advanced Cancer No drug interventions treatment 1 terminated NCT04678921
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors No drug interventions treatment 1 completed NCT01245621
Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III) No drug interventions supportive_care Not Available completed NCT05894421
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers No drug interventions treatment 1 recruiting NCT03137121
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients No drug interventions treatment 2 / 3 completed NCT00278902
A Study of ARRY-334543 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00637702
A Study of ARRY-334543 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT05398484
Psilocybin Therapy in Advanced Cancer No drug interventions treatment 2 / 3 recruiting NCT04065984
Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES) No drug interventions treatment Not Available active_not_recruiting NCT03027284
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT03833479
TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) No drug interventions treatment 2 active_not_recruiting NCT03526679
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT03811379
Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy No drug interventions treatment 2 unknown_status NCT00606879
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors No drug interventions treatment 1 terminated NCT05162443
Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation No drug interventions Not Available Not Available approved_for_marketing NCT00085787
A Study of ARRY-142886 in Patients With Advanced Cancer treatment 1 completed NCT00729833
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors treatment 1 terminated NCT01539733
Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer treatment Not Available completed NCT02193633
A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. treatment 1 completed NCT03829254
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma treatment 1 / 2 recruiting NCT04321954
Lenvatinib in Locally Advanced Invasive Thyroid Cancer treatment 2 recruiting NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) treatment 1 / 2 terminated NCT01087554
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer treatment 1 active_not_recruiting NCT04648254
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04385654
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma treatment 2 unknown_status NCT02261051
Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm No drug interventions Not Available Not Available withdrawn NCT01262651
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer treatment 3 completed NCT04317651
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03475251
A Study of CS1003 in Subjects With Advanced Solid Tumors treatment 1 completed NCT03444753
An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed treatment 1 terminated NCT04335253
First-In-Human Study of EOS884448 in Participants With Advanced Cancers. treatment 1 completed NCT05812677
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer No drug interventions treatment 0 recruiting NCT04823377
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. No drug interventions supportive_care Not Available recruiting NCT01583777
Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer treatment 1 completed NCT03668847
DM-CHOC-PEN for Brain Tumors in AYA Subjects treatment 2 completed NCT03432247
Pain Management Support Study for Patients With Advanced Cancer No drug interventions supportive_care Not Available completed NCT02580045
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer No drug interventions Not Available Not Available terminated NCT02889445
A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers Not Available Not Available no_longer_available NCT04310345
Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents No drug interventions supportive_care Not Available completed NCT05159245
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs treatment 2 recruiting NCT05557045
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 No drug interventions treatment 1 recruiting NCT03717298
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma No drug interventions supportive_care 2 completed NCT02455505
Identifying Family Members in Need of Support While Caregiving and After Loss No drug interventions Not Available Not Available active_not_recruiting NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04237805
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions treatment 1 / 2 recruiting NCT05364905
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma No drug interventions Not Available Not Available completed NCT05988697
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Not Available Not Available not_yet_recruiting NCT03532997
Extra Layer Of Support No drug interventions supportive_care Not Available completed NCT06457997
A Study of PHN-010 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT02801097
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) treatment 1 terminated NCT02666183
Online Information and Support for Distance Caregivers No drug interventions supportive_care Not Available completed NCT02469883
A Study of Sinotecean on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT00933361
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study treatment 1 / 2 completed NCT03579628
AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors No drug interventions treatment 1 completed NCT04945928
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC No drug interventions treatment Not Available active_not_recruiting NCT00895128
Study of Erlotinib in Combination With Dasatinib treatment 1 completed NCT05584111
Oral Administration of STC-15 in Subjects With Advanced Malignancies No drug interventions treatment 1 active_not_recruiting NCT02219711
Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer treatment 1 completed NCT04467593
Safety Study of Whole Body Hyperthermia for Advanced Cancer No drug interventions treatment Not Available recruiting NCT00489593
Olanzapine in Patients With Advanced Cancer and Weight Loss treatment 1 completed NCT02992171
Primary Palliative Care for Patients With Advanced Hematologic Malignancies No drug interventions supportive_care Not Available completed NCT00750178
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008) treatment 1 completed NCT03252678
Efficacy of Self-education Program for Advanced Care Planning(RCT) No drug interventions health_services_research Not Available completed NCT05103488
Comprehensive Palliative Care for Cancer Patients in Vietnam No drug interventions supportive_care Not Available completed NCT05320588
A Study in Patients With Advanced Cancers treatment 1 / 2 recruiting NCT05884788
Study of the Life Stories of Patients Making a Request for Euthanasia, in the Context of Advanced Cancer. No drug interventions Not Available Not Available recruiting NCT05408507
Care Planning Framework in Advanced Cancer (ABC123) No drug interventions treatment Not Available recruiting NCT03745807
An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors treatment 1 completed NCT00530907
Valproic Acid and Bevacizumab in Patients With Advanced Cancer treatment 1 completed NCT05605509
RP-6306 in Patients With Advanced Cancer treatment 2 recruiting NCT02014909
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors No drug interventions treatment 1 completed NCT02966509
Engagement of Patients With Advanced Cancer No drug interventions health_services_research Not Available completed NCT03008109
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC treatment 3 unknown_status NCT04975256
Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) treatment 1 completed NCT04308356
Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? No drug interventions Not Available Not Available unknown_status NCT01983956
A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial) No drug interventions supportive_care Not Available unknown_status NCT06416085
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer supportive_care 2 recruiting NCT05025085
A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01863485
Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China No drug interventions treatment 1 completed NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT00504985
Fatigue in Emergency Center Patients No drug interventions Not Available Not Available terminated NCT03986515
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma treatment 2 unknown_status NCT01901237
Yoga for Adolescent and Young Adult Non-Curative Cancer Patients No drug interventions supportive_care Not Available completed NCT03140137
Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases No drug interventions Not Available Not Available completed NCT01538537
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer treatment 1 completed NCT03440437
A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies treatment 1 / 2 terminated NCT03661632
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors treatment 1 completed NCT01209832
A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients basic_science 1 terminated NCT05060432
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT01295632
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049) treatment 1 completed NCT04419532
A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00798252
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers treatment 1 completed NCT03411200
Patient Activation Through Counseling, Exercise and Mobilization No drug interventions supportive_care Not Available completed NCT05394675
A Study of DS-9606a in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04584775
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care No drug interventions supportive_care Not Available withdrawn NCT00385775
Study of XIAP Antisense for Advanced Cancers treatment 1 terminated NCT03518970
Uncertainty in Illness in Palliative Care: an Intervention for Family Caregivers No drug interventions supportive_care Not Available unknown_status NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00664170
A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer treatment 1 completed NCT03904342
Sophie Pilot Implementation and Assessment No drug interventions supportive_care Not Available withdrawn NCT03312842
A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors treatment 1 completed NCT05047042
A Feasibility Study of a Virtual Rehabilitation and Physical Activity Program for People With Advanced Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT00625742
Multimodal Treatment Strategy for Cancer Cachexia treatment Not Available terminated NCT04441099
NBE-002 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT01187199
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer treatment 1 active_not_recruiting NCT02779699
A Study of AL2846 on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT03104699
Study of AGEN2034 in Advanced Tumors and Cervical Cancer treatment 1 / 2 completed NCT05749549
Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers No drug interventions treatment 1 / 2 active_not_recruiting NCT03122249
Oncology Associated Symptoms & Individualized Strategies No drug interventions supportive_care Not Available withdrawn NCT03503149
Molecular Tumor Board at the Center for Personalized Medicine Tübingen No drug interventions Not Available Not Available recruiting NCT01744249
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas treatment 2 / 3 unknown_status NCT04626349
International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their Families No drug interventions supportive_care Not Available completed NCT02944136
Collaborative Care Intervention for Cancer Caregivers No drug interventions supportive_care Not Available completed NCT00710736
A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer treatment 1 completed NCT01054313
Docetaxel and Sirolimus in Patients With Advanced Malignancies treatment 1 completed NCT05270213
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors treatment 1 recruiting NCT04407013
Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway No drug interventions other Not Available unknown_status NCT04900818
Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT03013218
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) treatment 1 active_not_recruiting NCT00761618
Intrapleural Catheter Daily Versus Three Times a Week Drainage No drug interventions treatment 2 active_not_recruiting NCT02684318
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors treatment 1 / 2 unknown_status NCT04471818
Ketamine or Placebo in Patients With Major Depression and Advanced Cancer treatment 1 / 2 completed NCT05420519
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer No drug interventions treatment 1 recruiting NCT03980041
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) treatment 2 completed NCT00698841
Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors treatment 2 completed NCT03761017
MGD019 DART® Protein in Unresectable/Metastatic Cancer treatment 1 active_not_recruiting NCT04257617
A Trial of ZL-1201 in Subjects With Advanced Cancer No drug interventions treatment 1 completed NCT04204434
Biomarkers For Immune Checkpoint Inhibitors No drug interventions Not Available Not Available completed NCT01524224
A Dose-Escalation Study in Participants With Advanced Cancer treatment 1 completed NCT04336124
Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients treatment 1 completed NCT02418624
Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer treatment 1 completed NCT02642016
A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01954316
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer treatment 1 completed NCT03780816
Variation in Cancer Centers' End-of-Life Quality No drug interventions Not Available Not Available completed NCT01394016
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer treatment 1 completed NCT00792896
Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease No drug interventions health_services_research Not Available unknown_status NCT06229158
Assessment of the Quality and Sexual Health Needs of Patients With Advanced-stage Cancer No drug interventions Not Available Not Available recruiting NCT03168035
Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00421135
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer treatment 1 completed NCT03104335
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial treatment 2 withdrawn NCT00707135
Rapamycin in Advanced Cancers treatment 1 completed NCT01538563
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer treatment 1 completed NCT04257786
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT06190886
A First-in-human (FIH), Multicenter, Open-Label, Phase I Study of PTX-912 in Patients With Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04121039
Study of the Apatinib Combine With POF Versus POF in Gastric Cancer treatment 2 unknown_status NCT03129139
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00423722
Parenteral Hydration in Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT02338622
Trial of Olaparib in Combination With AZD5363 (ComPAKT) treatment 1 completed NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT00970125
Using Video Images to Improve Advance Care Planning in Patients With Cancer No drug interventions health_services_research Not Available completed NCT03120130
Study of Amblyomin-X in Advanced Solid Tumor No drug interventions treatment 1 suspended NCT00529230
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes No drug interventions Not Available Not Available terminated NCT03099330
A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT05426330
Advanced Cancer Patients' and Their Primary Caregivers' Willingness to Communicate About Advance Care Planning (ACP) No drug interventions Not Available Not Available recruiting NCT01185548
A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma treatment 1 terminated NCT03565757
Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced Cancer No drug interventions supportive_care Not Available completed NCT02778126
A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer basic_science 1 completed NCT03546426
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies treatment 1 unknown_status NCT00508326
Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement treatment 1 completed NCT03507166
A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer No drug interventions treatment 2 completed NCT06540066
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 not_yet_recruiting NCT04124666
Clinical Study of Granulocyte Infusion for Advanced Cancer No drug interventions treatment 1 / 2 unknown_status NCT01424566
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer treatment 3 completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT05802420
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT05990920
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy No drug interventions treatment 1 active_not_recruiting NCT00832520
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight prevention 2 terminated NCT01287520
A Study of LY2090314 in Patients With Advanced or Metastatic Cancer treatment 1 completed NCT01463982
Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies treatment 1 completed NCT05137782
The Science of the Art of Palliative Care No drug interventions health_services_research Not Available completed NCT04376931
A Prospective Dose Finding Study of Iscador Infusion No drug interventions treatment 1 / 2 unknown_status NCT00770731
Study of Temsirolimus, Topotecan, and Bortezomib treatment 1 completed NCT03352531
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00708773
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors treatment 1 completed NCT04604873
The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI) No drug interventions supportive_care Not Available active_not_recruiting NCT04943627
Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA) treatment 3 withdrawn NCT05315427
Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer No drug interventions Not Available Not Available completed NCT00709176
Outcomes of Triaged Family Care in Advanced Cancer No drug interventions supportive_care Not Available completed NCT03203876
A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT04121676
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer treatment 1 active_not_recruiting NCT03019276
A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT03207360
Pain Coping Skills and Meaning-Centered Intervention No drug interventions treatment Not Available completed NCT00515060
Psychophysical Studies of Cancer Therapy Pain No drug interventions Not Available Not Available recruiting NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT05166694
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions No drug interventions treatment Not Available recruiting NCT00682994
Patient and Family Decision Making in the Palliative Care Setting No drug interventions Not Available Not Available completed NCT03177291
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC treatment 1 active_not_recruiting NCT04303091
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients No drug interventions other Not Available completed NCT00708591
Study of Rapamycin Plus Ketoconazole in Advanced Cancers treatment 1 completed NCT04071262
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer treatment 1 completed NCT00507962
Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement treatment 1 completed NCT00951262
Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China No drug interventions supportive_care 4 completed NCT04406662
Routine Evaluation of People Living With Cancer No drug interventions Not Available Not Available recruiting NCT05735080
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT01241929
Using Videos in Advance Care Planning for Patients With Advanced Cancer No drug interventions health_services_research Not Available completed NCT03525392
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. treatment 1 terminated NCT05298592
A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors treatment 1 active_not_recruiting NCT02130492
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) No drug interventions treatment 1 / 2 suspended NCT02507544
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer treatment 1 completed NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03123744
Histology-Independent Study of Palbociclib in Patients With Advanced Cancer treatment 2 withdrawn NCT05407844
Community Health Worker Based Intervention to Improve Palliative Care No drug interventions supportive_care Not Available enrolling_by_invitation NCT04435444
Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT05045040
Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions No drug interventions supportive_care Not Available recruiting NCT03335540
An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment treatment 1 completed NCT06302140
A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers basic_science 1 recruiting NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT03674567
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab treatment 1 / 2 active_not_recruiting NCT02069067
Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated No drug interventions Not Available Not Available active_not_recruiting NCT04869267
Acceptance and Commitment Therapy in Patients With Advanced Lung Cancer No drug interventions supportive_care Not Available completed NCT06239467
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer treatment 1 recruiting NCT02430467
Caregiver-Guided Pain Management Training in Palliative Care No drug interventions supportive_care Not Available completed NCT06240767
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils No drug interventions treatment 1 recruiting NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT01081301
Living With Hope Program for Rural Women Caregivers No drug interventions supportive_care 2 completed NCT06363201
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours No drug interventions supportive_care Not Available not_yet_recruiting NCT03994601
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers treatment 1 / 2 active_not_recruiting NCT00543504
Bevacizumab in Multiple Phase I Combinations treatment 1 completed NCT03371004
DM-CHOC-PEN Plus Radiation for Brain Tumors treatment 1 completed NCT02245204
Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers treatment 1 completed NCT00488072
Effects of Mirtazapine on Appetite in Advanced Cancer Patients treatment 2 active_not_recruiting NCT05200572
Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers No drug interventions supportive_care Not Available recruiting NCT02915172
Lenvatinib and Capecitabine in Patients With Advanced Malignancies treatment 1 withdrawn NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04936568
Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease No drug interventions health_services_research Not Available recruiting NCT06107868
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer treatment 1 active_not_recruiting NCT02745769
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents treatment 1 completed NCT04354246
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies treatment 1 recruiting NCT01287546
A Study of LY2875358 in Participants With Advanced Cancer treatment 1 completed NCT00955812
STAT3 Inhibitor for Solid Tumors No drug interventions treatment 1 completed NCT02432612
A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer treatment 1 withdrawn NCT02554812
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) treatment 1 / 2 terminated NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer treatment 1 / 2 completed NCT02777710
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers treatment 1 completed NCT03875781
Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer No drug interventions treatment 3 recruiting NCT01864681
Combination of Metformin With Gefitinib to Treat NSCLC treatment 2 completed NCT01367795
Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life No drug interventions Not Available Not Available completed NCT04640714
Care Transition Intervention for Patients With Cancer No drug interventions supportive_care Not Available completed NCT04757155
Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM) No drug interventions supportive_care Not Available recruiting NCT02671955
A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer No drug interventions treatment 1 terminated NCT03792750
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors treatment 1 / 2 completed NCT06215950
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer No drug interventions treatment 1 recruiting NCT06538350
Telemedicine in Palliative Care: Interventions, Experiences and Perceptions of Patients Diagnosed With Cancer No drug interventions other Not Available not_yet_recruiting NCT04110223
Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors No drug interventions Not Available Not Available unknown_status NCT03356223
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 treatment 2 completed NCT04833023
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial treatment 3 recruiting NCT01833923
A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics treatment 1 completed NCT04599608
Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients No drug interventions Not Available Not Available not_yet_recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination With IV DFMO treatment 1 / 2 suspended NCT04480008
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers No drug interventions supportive_care Not Available completed NCT04318808
Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer No drug interventions treatment Not Available unknown_status NCT00625638
Interactive Voice Response System in Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT02996838
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics No drug interventions treatment 1 unknown_status NCT00214838
An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer treatment 1 / 2 unknown_status NCT01977638
Phase 1 Trial of CXD101 in Patients With Advanced Cancer treatment 1 completed NCT03192943
A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors No drug interventions treatment 1 completed NCT03243643
Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors No drug interventions other 1 unknown_status NCT00477243
Locus of Control and Spirituality in Palliative Care Patients No drug interventions Not Available Not Available completed NCT00608803
Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors No drug interventions treatment 1 completed NCT04672603
Complete Versus Partial Preservation of Denonvilliers' Fascia on Urogenital Function in Locally Advanced Rectal Cancer No drug interventions treatment Not Available recruiting NCT01423903
Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer No drug interventions treatment 1 completed NCT01394003
A Study of LY2584702 in Participants With Advanced Cancer No drug interventions treatment 1 terminated NCT01115790
A Phase 1 Study in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT01393990
A Study of LY2228820 in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT06405490
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC No drug interventions treatment 2 recruiting NCT00591890
Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans No drug interventions treatment 1 completed NCT04772690
Balance, Activity and Quality of Life No drug interventions supportive_care Not Available completed NCT04270864
Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers No drug interventions treatment 1 active_not_recruiting NCT04330664
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) No drug interventions treatment 1 active_not_recruiting NCT01545921
Cancer End Of Life Evaluation No drug interventions supportive_care Not Available terminated NCT04396821
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03040102
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers No drug interventions supportive_care Not Available completed NCT04648202
FS120 Phase 1/1b Study in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT01380184
Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059) No drug interventions treatment 1 completed NCT05885984
Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT) No drug interventions supportive_care Not Available not_yet_recruiting NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT01143779
FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib No drug interventions treatment 1 completed NCT03391479
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy No drug interventions treatment 2 recruiting NCT04861987
A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors No drug interventions treatment 1 active_not_recruiting NCT06067087
Prognostic Understanding in ESC (ProgESC Study) No drug interventions Not Available Not Available not_yet_recruiting NCT00895687
Study of Erlotinib in Combination With Bortezomib No drug interventions treatment 1 completed NCT06174987
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) No drug interventions treatment 3 recruiting NCT03285633
Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer No drug interventions treatment Not Available completed NCT03181854
Randomized Controlled Trial of Integrated Early Palliative Care No drug interventions supportive_care Not Available completed NCT03690154
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML No drug interventions treatment 1 terminated NCT00507754
Latent Tuberculosis Infection in Cancer Patients No drug interventions Not Available Not Available completed NCT02331251
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) No drug interventions treatment 1 / 2 terminated NCT01505153
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer No drug interventions treatment 1 completed NCT00543153
The Exceptional Patient in Cancer Care No drug interventions Not Available Not Available completed NCT02529553
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT02711553
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer No drug interventions treatment 2 active_not_recruiting NCT04859777
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT05971277
Home And Locally Observed - Tracking (HALO-Trak) No drug interventions Not Available Not Available recruiting NCT02992977
Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer No drug interventions treatment 1 terminated NCT01313247
Paracetamol for Cancer Pain No drug interventions treatment 4 unknown_status NCT05204147
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers No drug interventions treatment 1 recruiting NCT05142345
Care Transition Intervention for Hospitalized Patients With Advanced Cancer No drug interventions supportive_care Not Available unknown_status NCT01567345
Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow No drug interventions treatment Not Available completed NCT04146298
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 recruiting NCT02703298
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients No drug interventions treatment 1 completed NCT04738305
Feasibility of Dignity Therapy Intervention on Cancer Patients in Charge to an Hospital Palliative Care Unit. No drug interventions supportive_care Not Available completed NCT00687505
Safety Study of FP-1039 To Treat Cancer No drug interventions treatment 1 completed NCT04250597
Study of GNX102 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06346197
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas No drug interventions treatment 3 not_yet_recruiting NCT06389097
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization No drug interventions Not Available Not Available not_yet_recruiting NCT02747797
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations No drug interventions treatment 2 withdrawn NCT04141397
Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care No drug interventions Not Available Not Available unknown_status NCT04042597
Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma No drug interventions treatment 2 unknown_status NCT01462383
The Role of the EKG in Anticancer Drug Development No drug interventions Not Available Not Available completed NCT06338683
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer No drug interventions treatment 3 recruiting NCT05782361
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC No drug interventions health_services_research 1 recruiting NCT00656461
Phase 1 Study of MKC-1 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT01611961
Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients No drug interventions treatment 1 unknown_status NCT03536728
Oral AMXT 1501 Dicaprate in Combination With DFMO No drug interventions treatment 1 completed NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. No drug interventions Not Available Not Available recruiting NCT06082128
FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers No drug interventions supportive_care Not Available not_yet_recruiting NCT03261011
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00607711
Study of Oral Palifosfamide Tris in Solid Tumors No drug interventions treatment 1 suspended NCT00610493
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy No drug interventions treatment 1 completed NCT03605771
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain No drug interventions Not Available Not Available recruiting NCT01339871
Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT00658671
A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00994578
Intervention Study of Communication in Oncologist-Patient Encounters No drug interventions Not Available Not Available completed NCT02112188
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer No drug interventions Not Available Not Available recruiting NCT03110107
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT01361607
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer No drug interventions treatment 3 completed NCT01212107
A Phase 1 Study of LY2874455 in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT03561207
3D Prediction of Patient-Specific Response No drug interventions Not Available Not Available active_not_recruiting NCT06117709
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing No drug interventions health_services_research Not Available not_yet_recruiting NCT06420609
Efficacy of a Proactive Approach to Death Thoughts in People With Advanced Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT04942756
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. No drug interventions supportive_care Not Available unknown_status NCT03042156
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy No drug interventions Not Available Not Available active_not_recruiting NCT01226485
A Study in Advanced Cancer No drug interventions treatment 1 completed NCT03325985
Emergency Medicine Palliative Care Access No drug interventions supportive_care Not Available completed NCT00667485
Rapamycin Plus Bevacizumab in Advanced Cancers No drug interventions treatment 1 completed NCT04590885
Coping Together: Couple-based Interventions for Cancer No drug interventions supportive_care Not Available recruiting NCT02470715
Identifying Molecular Drivers of Cancer No drug interventions Not Available Not Available completed NCT05136937
A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04148937
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT03375437
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. No drug interventions screening Not Available active_not_recruiting NCT00697632
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies No drug interventions treatment 1 completed NCT03837132
Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer No drug interventions Not Available Not Available completed NCT03763032
Psychosocial Intervention in Latino Patients With Advanced Cancer No drug interventions supportive_care Not Available completed NCT02583932
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer No drug interventions supportive_care 3 completed NCT05076552
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 active_not_recruiting NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00629200
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT04158700
A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer No drug interventions treatment 1 / 2 withdrawn NCT06285500
Umbrella Study for Single Patient Treatments in Oncology No drug interventions Not Available Not Available recruiting NCT03645200
Treatment of Carrying TP53 Harmful Mutations No drug interventions treatment 1 unknown_status NCT03936959
A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer No drug interventions treatment 1 completed NCT05082259
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab No drug interventions health_services_research 1 recruiting NCT05853575
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) No drug interventions treatment 2 recruiting NCT02737475
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread No drug interventions treatment 1 / 2 completed NCT03219775
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma No drug interventions treatment 2 unknown_status NCT04398875
Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial No drug interventions treatment Not Available unknown_status NCT06120075
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies No drug interventions treatment 1 recruiting NCT06010875
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02857270
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer No drug interventions treatment 1 completed NCT01197170
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance No drug interventions treatment 1 completed NCT01214642
A Dose-Escalation Study for Patients With Advanced Cancer No drug interventions treatment 1 completed NCT03900442
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort No drug interventions treatment 1 unknown_status NCT05438342
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis No drug interventions treatment Not Available unknown_status NCT00684242
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain No drug interventions treatment 2 terminated NCT05262842
JS001+IMP4297 in Patients With Advanced Cancer No drug interventions treatment 1 withdrawn NCT02136342
Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT03730142
A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT03195699
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers No drug interventions treatment 1 active_not_recruiting NCT03765099
Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents No drug interventions supportive_care Not Available completed NCT00424099
Methylphenidate and a Nursing Telephone Intervention for Fatigue No drug interventions supportive_care 2 / 3 completed NCT00607399
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors No drug interventions treatment 1 terminated NCT05315999
Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care No drug interventions treatment 2 recruiting NCT05113199
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT04089306
Integration of Palliative Care in an Oncology and Hematology Unit No drug interventions Not Available Not Available unknown_status NCT01576406
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients No drug interventions basic_science 1 completed NCT04012749
UC Health Care Planning Study No drug interventions supportive_care Not Available active_not_recruiting NCT00687349
Improving Clinician Communication Skills (ICCS) No drug interventions supportive_care 3 completed NCT03785249
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 No drug interventions treatment 1 / 2 recruiting NCT03387436
The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care Planning No drug interventions supportive_care Not Available unknown_status NCT06090513
Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03823313
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention No drug interventions supportive_care Not Available completed NCT03325218
Survival Expectations and Hope Among Cancer Patients at End-of-Life No drug interventions Not Available Not Available unknown_status NCT04864418
AST-021p Study in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05028218
A Clinical Study of TQB3824 in Subjects With Advanced Cancer No drug interventions treatment 1 recruiting NCT03582618
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 terminated NCT03979118
Exercise Prescription in Patients With Bone Metastases No drug interventions Not Available Not Available completed NCT05450419
The Role of Vitamin D3 Supplementation in Advanced Cancer Patients With Pain No drug interventions supportive_care Not Available recruiting NCT04193319
Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects No drug interventions other 1 completed NCT03258541
Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy No drug interventions treatment Not Available terminated NCT05910541
The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers No drug interventions supportive_care Not Available completed NCT00450541
Fatigue Experience in Cancer Patients No drug interventions Not Available Not Available completed NCT01887041
Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer No drug interventions supportive_care 4 terminated NCT01543841
Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood No drug interventions Not Available Not Available completed NCT00965341
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients No drug interventions treatment 3 completed NCT01929941
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies No drug interventions treatment 1 terminated NCT03833817
Patient-caregiver Communication Intervention for Prognostic Understanding No drug interventions supportive_care Not Available completed NCT02332317
Early, Integrated, Specialized Palliative Rehabilitation No drug interventions supportive_care Not Available completed NCT06081517
Evaluating Disparities in Precision Oncology No drug interventions Not Available Not Available recruiting NCT00429234
Gemcitabine and Dasatinib in Advanced Solid Tumors No drug interventions treatment 1 completed NCT03909334
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 active_not_recruiting NCT04740424
FS222 First in Human Study in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT02841124
Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies. No drug interventions Not Available Not Available completed NCT06188624
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers No drug interventions treatment 1 recruiting NCT00862524
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT00895024
Caregiver Assessments of the Quality of Home Hospice Care No drug interventions Not Available Not Available terminated NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT03667716
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. No drug interventions treatment 1 completed NCT05004116
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer No drug interventions treatment 1 / 2 recruiting NCT03763396
Azoles Targeting Recurrent High Grade Gliomas No drug interventions other 0 not_yet_recruiting NCT02919696
A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers No drug interventions treatment 1 completed NCT05735496
Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers No drug interventions treatment 1 not_yet_recruiting NCT04495296
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03714958
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type No drug interventions treatment 1 completed NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT03568058
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers No drug interventions treatment 1 active_not_recruiting NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) No drug interventions treatment 2 active_not_recruiting NCT06323135
Nutrition Assessment in Advanced Cancer Patients No drug interventions Not Available Not Available completed NCT02825563
A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients No drug interventions treatment 1 completed NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma No drug interventions treatment 1 completed NCT03722186
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies No drug interventions treatment 1 suspended NCT00980239
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver No drug interventions treatment 1 completed NCT00518739
MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) No drug interventions treatment 1 completed NCT05128539
A Study Explore JS001+JS002 in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT03810339
Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT03459222
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread No drug interventions treatment 1 / 2 active_not_recruiting NCT00980122
Aggressiveness of Care at the End of Life in Cancer Patients No drug interventions Not Available Not Available completed NCT01015222
Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT00591422
Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas No drug interventions treatment 1 unknown_status NCT02341625
A Study of BMS-986148 in Patients With Select Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT01655225
A Study of LY3023414 in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT06118125
Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement No drug interventions Not Available Not Available completed NCT00147225
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin No drug interventions prevention 1 / 2 completed NCT06093425
Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma No drug interventions treatment 3 not_yet_recruiting NCT00621725
Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours No drug interventions treatment 1 completed NCT05877430
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer No drug interventions treatment 1 / 2 recruiting NCT05154630
Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors No drug interventions treatment 1 / 2 terminated NCT01444157
Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients No drug interventions supportive_care 3 completed NCT04386057
LY3214996 +/- HCQ in Pancreatic Cancer No drug interventions treatment 2 completed NCT03316157
Exercise and Nutritional Rehabilitation in Patients With Cancer No drug interventions supportive_care Not Available completed NCT00634257
Spirituality/Religiosity in Patients and Caregivers No drug interventions Not Available Not Available completed NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT02884726
Phase 1 Study of Mesothelin-ADC No drug interventions treatment 1 completed NCT04254926
Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT00408226
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT00106626
Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors No drug interventions treatment 1 completed NCT00785226
RDEA119 and Sorafenib Combination Dose Escalation Study No drug interventions treatment 1 / 2 completed NCT00833326
A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT01072266
A Dose-escalation Study in Subjects With Advanced Malignancies No drug interventions treatment 1 completed NCT01347866
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer No drug interventions basic_science 1 terminated NCT03425565
A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer No drug interventions treatment 2 active_not_recruiting NCT02957565
Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit No drug interventions supportive_care Not Available completed NCT01417065
Temsirolimus In Phase 0 No drug interventions treatment 0 completed NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer No drug interventions treatment 1 active_not_recruiting NCT00951574
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) No drug interventions prevention 3 completed NCT00438620
The Feasibility of Physical Activity in Advanced Cancer Patients No drug interventions Not Available Not Available completed NCT03671720
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden No drug interventions treatment 0 withdrawn NCT00559182
A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001) No drug interventions treatment 1 completed NCT03002831
Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer No drug interventions treatment 2 terminated NCT01527331
A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer No drug interventions health_services_research Not Available unknown_status NCT00629473
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT03254173
Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia No drug interventions treatment 2 / 3 completed NCT01113476
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies No drug interventions treatment 1 completed NCT00385476
Cancer Patients' Medication Knowledge in the Emergency Center No drug interventions Not Available Not Available completed NCT06210776
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH) No drug interventions Not Available Not Available recruiting NCT02930876
Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients No drug interventions supportive_care 2 completed NCT02805660
Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC No drug interventions treatment 1 / 2 terminated NCT01660360
Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT03383094
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer No drug interventions treatment 2 recruiting NCT00610194
Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients No drug interventions treatment 1 completed NCT05375994
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients No drug interventions treatment 1 / 2 recruiting NCT02743494
An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer No drug interventions treatment 3 active_not_recruiting NCT01688791
A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) No drug interventions treatment 1 terminated NCT00512291
Subcutaneous Olanzapine for Hyperactive or Mixed Delirium No drug interventions treatment Not Available completed NCT01693991
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) No drug interventions supportive_care 1 completed NCT04339062
Cemiplimab in AlloSCT/SOT Recipients With CSCC No drug interventions treatment 1 / 2 active_not_recruiting NCT00513162
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases No drug interventions treatment 1 completed NCT03941262
Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy No drug interventions treatment 1 completed NCT06092580
Phase 1 Study of AWT020 in Advanced Cancer No drug interventions treatment 1 recruiting NCT00581880
Measuring Hope and Hopelessness in Cancer No drug interventions Not Available Not Available completed NCT04991480
A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02860780
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT03094780
Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers No drug interventions supportive_care Not Available completed NCT01361529
Safety Study of FLP Injection to Treat Tumor Patients No drug interventions treatment 1 unknown_status NCT02712229
A Primary Palliative Care Intervention for Patients With Advanced Cancer No drug interventions supportive_care Not Available completed NCT01214629
A Study for Participants With Advanced Cancer No drug interventions treatment 1 completed NCT03323489
Celiac Plexus Radio-Surgery for Pain Management No drug interventions treatment Not Available completed NCT02655289
Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients No drug interventions supportive_care Not Available completed NCT02980289
DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. No drug interventions Not Available Not Available completed NCT03554889
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells No drug interventions treatment 1 unknown_status NCT01337089
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain No drug interventions treatment 3 completed NCT00505544
Measuring Sleep Disturbance Among Cancer Patients No drug interventions Not Available Not Available completed NCT00761644
Doxil, Bevacizumab and Temsirolimus Trial No drug interventions treatment 1 completed NCT04606940
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) No drug interventions Not Available Not Available completed NCT01596140
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer No drug interventions treatment 1 completed NCT03446040
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread No drug interventions treatment 1 / 2 active_not_recruiting NCT00878267
Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study No drug interventions Not Available Not Available completed NCT03954067
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors No drug interventions treatment 1 completed NCT02318901
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer No drug interventions treatment 1 / 2 terminated NCT03030001
PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies No drug interventions treatment 1 / 2 unknown_status NCT05403801
STAMP+CBT mHealth for Cancer Pain No drug interventions supportive_care Not Available recruiting NCT04840004
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT03922204
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies No drug interventions treatment 1 unknown_status NCT04149704
Videos for Advance Care Planning in Young Adults No drug interventions health_services_research Not Available completed NCT03510104
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01158404
Notch Inhibitor in Advanced Cancer No drug interventions treatment 1 completed NCT06548672
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer No drug interventions treatment 1 recruiting NCT00736372
A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT03860272
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer No drug interventions treatment 1 recruiting NCT01644968
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT01296568
C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT02383368
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma No drug interventions treatment 1 completed NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy No drug interventions treatment 1 / 2 recruiting NCT00881569
Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017 No drug interventions treatment 1 completed NCT03851146
A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours No drug interventions treatment 1 completed NCT05192512
Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers No drug interventions treatment 1 recruiting NCT03260712
Pembrolizumab in Biliary Tract Cancer No drug interventions treatment 2 completed NCT05663710
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC No drug interventions treatment 1 / 2 active_not_recruiting NCT01358110
Emergency Department-Based Palliative Care for Advanced Cancer Patients No drug interventions health_services_research Not Available completed NCT01976910
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" No drug interventions treatment 1 completed NCT00634010
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain No drug interventions treatment 3 terminated NCT05276310
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy No drug interventions treatment 1 recruiting NCT04001010
Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia No drug interventions treatment 3 suspended NCT00423410
A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer No drug interventions treatment 1 completed NCT02996110
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma No drug interventions treatment 2 completed NCT05840510
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) No drug interventions treatment 1 active_not_recruiting NCT00940381
Sirolimus and Cetuximab in Advanced Malignancies No drug interventions treatment 1 completed NCT03751995
POEM (Practice of Embracing Each Moment) Study (Delivery Science) No drug interventions supportive_care Not Available completed NCT02797795
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers No drug interventions treatment 1 unknown_status NCT00493714
Delirium Recall in Advanced Cancer Patients No drug interventions Not Available Not Available completed NCT02750514
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT00430014
Study of Atiprimod Treatment for Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT03408314
The PediQUEST Response Intervention Study No drug interventions supportive_care Not Available completed NCT05525455
TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88) No drug interventions treatment 1 / 2 terminated NCT06200155
Psilocybin-Assisted Psychotherapy in Patients with Advanced Cancer on Maintenance Therapy No drug interventions supportive_care 2 recruiting NCT04289155
Individual Patient Compassionate Use of GX-I7 No drug interventions Not Available Not Available no_longer_available NCT03832855
Assessing the Immunogenicity of pING-hHER3FL No drug interventions other 1 recruiting NCT00551850
A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients No drug interventions treatment 1 completed NCT03098550
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread No drug interventions treatment 1 / 2 completed NCT03369223
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT02357108
Message: Study of Patients' Perception of Physician's Compassion No drug interventions Not Available Not Available completed NCT04095208
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study No drug interventions treatment 2 recruiting NCT01048008
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00907738
A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) No drug interventions treatment 2 completed NCT04606238
Decision Aid to Support Advanced Cancer Patients No drug interventions health_services_research Not Available recruiting NCT00688038
Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy No drug interventions treatment 4 completed NCT03610243
Patient-centered Self-administered Acupressure for Fatigue Management in Chinese Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT04545827
Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumours basic_science 1 not_yet_recruiting NCT01479309
Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b treatment 2 withdrawn NCT04186884
Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings No drug interventions Not Available Not Available completed NCT02286687
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes treatment 2 active_not_recruiting NCT06344351
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer No drug interventions treatment 1 recruiting NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies No drug interventions treatment 1 recruiting NCT06165809
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer No drug interventions treatment 1 withdrawn NCT06297642
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. treatment 1 terminated NCT04067336
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia treatment 1 / 2 recruiting NCT06394713
A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors treatment 1 / 2 not_yet_recruiting NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT05867563
Clinical Trial Evaluating the Safety of the TQB2103 for Injection No drug interventions treatment 1 recruiting NCT03122886
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin No drug interventions supportive_care Not Available active_not_recruiting NCT03021486
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer supportive_care 2 / 3 active_not_recruiting NCT03203525
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer treatment 1 recruiting NCT03856060
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits No drug interventions supportive_care Not Available active_not_recruiting NCT01867294
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab supportive_care 2 completed NCT01582191
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer treatment 1 active_not_recruiting NCT01549067
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey No drug interventions Not Available Not Available unknown_status NCT00244972
Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer treatment 1 completed NCT02583269
Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery No drug interventions treatment 1 completed NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) treatment 1 / 2 recruiting NCT03049397
Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer No drug interventions supportive_care Not Available terminated NCT02650583
Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children No drug interventions supportive_care Not Available completed NCT01531361
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations No drug interventions treatment 1 completed NCT05985278
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy No drug interventions treatment 0 recruiting NCT04119037
Cordotomy in Reducing Pain in Patients With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT02491632
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer No drug interventions supportive_care 2 / 3 active_not_recruiting NCT02823652
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer No drug interventions health_services_research Not Available completed NCT03592459
Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer No drug interventions device_feasibility Not Available withdrawn NCT05997342
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor No drug interventions treatment 1 not_yet_recruiting NCT06581419
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT04053517
Financial Distress in Advanced Cancer Patients No drug interventions Not Available Not Available active_not_recruiting NCT01552434
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease No drug interventions treatment 1 active_not_recruiting NCT03051035
First-in-Human Study of KO-947 in Non-Hematological Malignancies No drug interventions treatment 1 terminated NCT06165822
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets No drug interventions treatment 1 not_yet_recruiting NCT03671226
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center No drug interventions supportive_care Not Available active_not_recruiting NCT01624766
Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers No drug interventions treatment 1 completed NCT04503265
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study No drug interventions Not Available Not Available active_not_recruiting NCT03525873
Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy No drug interventions treatment 3 active_not_recruiting NCT05048160
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm No drug interventions treatment 1 / 2 recruiting NCT03287492
RCT of QPS vs General Information Sheet No drug interventions supportive_care Not Available active_not_recruiting NCT03069469
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor No drug interventions treatment 1 / 2 active_not_recruiting NCT03868423
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers No drug interventions treatment 2 withdrawn NCT02940223
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer No drug interventions supportive_care 2 terminated